Chinese Academy of Sciences Innovation

Chinese Academy of Sciences Innovation and Investment Co., Ltd. (CAS Innovation) is the primary commercialization and investment arm of the Chinese Academy of Sciences (CAS), the world's largest research organization. Founded in 2015 and headquartered in Beijing, the company serves as a strategic platform for translating scientific breakthroughs from CAS's 100+ research institutes into commercial ventures, with a core focus on the life sciences and biotechnology sectors. CAS Innovation manages a diverse portfolio of biomedical projects and has established key international partnerships, such as its strategic collaboration with HUYA Bioscience International, to accelerate the global development of China-sourced innovative drugs. The company provides investment, incubation, and technology transfer services to foster the industrialization of high-end R&D in areas including oncology, neurology, and cardiovascular health.